Cooperative alterations of Rb pathway regulators in mouse primary T cell lymphomas

Carcinogenesis

Volumn 20, Issue 9, 1999, Pages 1675-1682

  Perez De Castro I ^a,b   Malumbres, M ^a   Santos, J ^b   Pellicer, A ^a   Fernandez Piqueras J ^b  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; PROTEIN P15; PROTEIN P16; RETINOBLASTOMA PROTEIN; RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE MUTATION; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; ONCOGENE K RAS; ONCOGENE N RAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SYNTHESIS; T CELL LYMPHOMA; TUMOR SUPPRESSOR GENE;

ANIMALS; CARRIER PROTEINS; CELL CYCLE; CELL CYCLE PROTEINS; CODON; CYCLIN D1; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASES; DNA MUTATIONAL ANALYSIS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P16; GENES, RAS; GENES, RETINOBLASTOMA; LYMPHOMA, T-CELL; MALE; MICE; MICE, INBRED C57BL; NEOPLASM PROTEINS; NEOPLASMS, RADIATION-INDUCED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROTO-ONCOGENE PROTEINS; RETINOBLASTOMA PROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR PROTEINS;

EID: 19244369408     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/20.9.1675     Document Type: Article

References (62)

1. Guerrero, I. and Pellicer, A. (1987) Mutational activation of oncogenes in animal models systems of carcinogenesis. Mutat. Res., 185, 293-308.
2. Diamond, L.E., Guerrero, I. and Pellicer, A. (1988) Concominant K- and N-ras gene point mutations in clonal murine lymphoma. Mol. Cell. Biol., 8, 2233-2236.
3. Newcomb, E.W., Steinberg, J.J. and Pellicer, A. (1988) ras oncogenes and phenotypic staging in N-methylnitrosourea- and gamma-irradiation-induced thymic lymphomas in C57BL/6J mice. Cancer Res., 48, 5514-5521.
4. Newcomb, E.W. (1997) Clonal evolution of N-methylnitrosourea-induced C57BL/6J thymic lymphomas by analysis of multiple genetic alterations. Leuk. Res., 21, 189-198.
5. McMorrow, L.E., Newcomb, E.W. and Pellicer, A. (1988) Identification of a specific marker chromosome early in tumor development in γ-irradiated C57BL/6J mice. Leukemia, 2, 115-119.
6. Brathwaite, O., Bayona, W. and Newcomb, E. (1992) p53 mutations in C57BL/6J murine thymic lymphomas induced by γ-irradiation and N-methylnitrosourea. Cancer Res., 52, 3791-3795.
7. Sáez, G.T., Oliva, M.R., Mangues, R. and Pellicer, A. (1994) Absence of MDM-2 gene amplification in experimentally induced tumors regardless of p53 status. Mol. Carcinog., 9, 40-45.
8. Zhuang, S.-M., Cochran, C., Goodrow, T., Wiseman, R.W. and Söderkvist, P. (1997) Genetic alterations of p53 and ras genes in 1,3-butadiene-and 2′,3′-dideoxycytidine-induced lymphomas. Cancer Res., 57, 2710-2714.
9. Santos, J., Pérez de Castro, I., Herranz, M., Pellicer, A. and Fernández-Piqueras, J. (1996) Allelic losses on chromosome 4 suggest the existence of a candidate tumor suppressor gene region of about 0.6 cM in γ-radiation-induced mouse primary thymic lymphomas. Oncogene, 12, 669-676.
10. O'Brien, S.J., Womack, J.E., Lyons, L.A., Moore, K.J., Jenkins, N.A. and Copeland, N.G. (1993) Anchored reference loci for comparative genome mapping in mammals. Nature Genet., 3, 103-112.
11. Lyons, L.A., Laughlin, T.F., Copeland, N.G., Jenkins, N.A., Womack, J.E. and O'Brien, S.J. (1997) Comparative anchor tagged sequences (CATS) for integrative mapping of mammalian genomes. Nature Genet., 15, 47-56.
12. Olapade, O.I., Buchhagen, D.L., Malik, K., Sherman, J., Nobori, T., Bader, S., Nau, M.M., Gazdar, A.F., Minna, J.D. and Diaz, M.O. (1993) Homozygous loss of the interferon genes defines the critical region on 9p that is deleted in lung cancers. Cancer Res., 53, 2410-2415.
13. Bohlander, S.K., Dreyling, M.H., Hagos, F., Sveen, L., Olapade, O.I. and Diaz, M.O. (1994) Mapping a putative tumor suppressor gene on chromosome 9 bands p21-p22 with microdissection probes. Genomics, 24, 211-217.
14. Chaganti, S.R., Gaidano, G., Louie, D.C., Della-Favera, R. and Chaganti, R.S.K. (1995) Diffuse large cell lymphomas exhibit frequent deletions in 9p21-22 and 9q31-34 regions. Genes Chromosomes Cancer, 12, 32-36.
15. Stone, S., Dayananth, P., Jiang, P., Weaver-Feldhaus, J.M., Tavtigian, S.V., Cannon-Albright, L. and Kamb, A. (1995) Genomic structure, expression and mutational analysis of the p15 (MTS2) gene. Oncogene, 11, 987-991.
16. Pollock, P.M., Pearson, J.V. and Hayward, N.K. (1996) Compilation of somatic mutations of the CDKN2 gene in human cancers: non-random distribution of base substitution. Genes Chromosomes Cancer, 15, 77-88.
17. Merlo, A., Herman, J.G., Mao, L., Lee, D.J., Gabrielson, E., Burger, P.C., Baylin, S.B. and Sidransky, D. (1995) 5′ CpG island methylation is associated with transcriptional silencing of the tumour supressor p16/CDKN2/MTS1 in human cancers. Nature Med., 1, 686-692.
18. Herman, J.G., Merlo, A., Mao, L., Lapidus, R.G., Issa, J.-P.J., Davidson, N.E., Sidransky, D. and Baylin, S.B. (1995) Inactivation of the CDKN2/p16/ MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res., 55, 4525-4530.
19. González-Zulueta, M., Bender, C.M., Yang, A.S., Nguyen, T., Beart, R.W., van Tornout, J.M. and Jones, P.A. (1995) Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res., 55, 4531-4535.
20. INK4A protein induction by 5-aza-2′-deoxycytidine. Oncogene, 11, 1211-1216.
21. INK4B. Cancer Res., 56, 722-727.
22. INK4a alterations in murine primary T-cell lymphomas. Oncogene, 14, 1361-1370.
23. INK4A characterize the major types of hematological malignancies. Cancer Res., 57, 837-841.
24. Batova, A., Diccianni, M.B., Yu, J.C., Nobori, T., Link, M.P., Pullen, J. and Yu, A.L. (1997) Frequent and selective methylation of p15 and deletion of both p15 and p16 in T-cell acute lymphoblastic leukemia. Cancer Res., 57, 832-836.
25. Serrano, M., Hannon, G.J. and Beach, D. (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature, 366, 704-707.
26. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature, 371, 257-260.
27. Graña, X. and Reddy, E.P. (1995) Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinases inhibitors (CKIs). Oncogene, 11, 211-219.
28. Sherr, C.J. (1996) Cancer cell cycles. Science, 274, 1672-1677.
29. Hall, M. and Peters, G. (1996) Genetic alterations of cyclins, cyclin-dependent kinases, and CDK inhibitors in human cancer. Adv. Cancer Res., 68, 67-108.
30. Winston, J.T., Coats, S.R., Wang, Y.-Z. and Pledger, W.J. (1996) Regulation of the cell cycle machinery by oncogenic ras. Oncogene, 12, 127-134.
31. Jiang, W., Kahn, S.M., Guillem, J.G., Lu, S.-H. and Weinstein, B. (1989) Rapid detection of ras oncogenes in human tumors: applications to colon, esophageal, and gastric cancer. Oncogene, 4, 923-928.
32. Jacobson, D.R. and Moskovits, T. (1991) Rapid, nonradioactive screening for activating ras oncogene mutations using PCR-primer introduced restriction analysis (PCR-PIRA). PCR Methods Appl., 1, 146-148.
33. Leon, J., Guerrero, I. and Pellicer, A. (1987) Differential expression of the ras gene family in mice. Mol. Cell. Biol., 7, 1535-1540.
34. Mangues, R., Kalhn, J.M., Seidman, I. and Pellicer, A. (1994) An overexpressed N-ras proto-oncogene cooperates with N-methylnitrosourea in mouse mammary carcinogenesis. Cancer Res., 54, 6395-6401.
35. Bernards, R., Schackleford, G.M., Gerber, M.R. et al. (1989) Structure and expression of the murine retinoblastoma gene and characterization of its encoded protein. Proc. Natl Acad. Sci. USA, 86, 6474-6478.
36. Matsushime, H., Roussel, M.F., Ashmun, R.A. and Sherr, C.J. (1991) Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell, 65, 701-713.
37. Bianchi, A.B., Fischer, S.M., Robles, A.I., Rinchik, E.M. and Conti, C.J. (1993) Overexpression of cyclin D1 in mouse skin carcinogenesis. Oncogene, 8, 1127-1133.
38. Melendez, B., Santos, J. and Fernandez-Piqueras, J. (1999) Loss of heterozygosity at the proximal-mid part of mouse chromosome 4 defines two novel tumor suppressor gene loci in T-cell lymphomas. Oncogene, in press.
39. INK4A-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science, 269, 1281-1284.
40. Bos, J.L. (1989) ras oncogenes in human cancer: a review. Cancer Res., 49, 4682-4689.
41. INK4A or retinoblastoma protein (pRb), or amplification-associated overexpression of cdk4 is observed in distinct subsets of malignant glial tumors and cell lines. Cancer Res., 55, 4833-4836.
42. Khatib, Z.A., Matsushime, H., Valentine, M., Shapiro, D.N., Sherr, C.J. and Look, A.T. (1993) Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas. Cancer Res., 53, 5335-5341.
43. Sgambato, A., Han, E.K.-H., Zhang, Y.-J., Moon, R.C., Santella, R.M. and Weinstein, I.B. (1995) Deregulated expression of cyclin D1 and other cell cycle-related genes in carcinogen-induced rat mammary tumors. Carcinogenesis, 16, 2193-2198.
44. Zhang, T., Nanney, L.B., Luongo, C., Lamps, L., Heppner, K.J., DuBois, R.N. and Beauchamp, R.D. (1997) Concurrent overexpression of cyclin D1 and cyclin-dependent kinase 4 (Cdk4) in intestinal adenomas from multiple intestinal neoplasia (Min) mice and human familial adenomatous polyposis patients. Cancer Res., 57, 169-175.
45. Lammie, G.A., Smith, R., Silver, J., Brookes, S., Dickson, C. and Peters, G. (1992) Proviral insertions near cyclin D1 in mouse lymphomas: a parallel for BCL1 translocations in human B-cell neoplasms. Oncogene, 7, 2381-2387.
46. Robles, A.I. and Conti, C.J. (1995) Early overexpression of cyclin D1 protein in mouse skin carcinogenesis. Carcinogenesis, 16, 781-786.
47. Bartkova J., Lukas, J., Guldberg, P., Alsner, J., Kirkin, A.F., Zeuthen, J. and Bartek, J. (1996) The p16-cyclin D/CDK4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis. Cancer Res., 56, 5475-5483.
48. INK4/CDKN2 and cyclin D1 cooperate to deregulate G1 control. Cancer Res., 55, 4818-4823.
49. Olshan, A.F., Weissler, M.C., Pei, H., Conway, K., Anderson, S., Fried, D.B. and Yarbrough, W.G. (1997) Alterations of the p16 gene in head and neck cancer: frequency and association with p53, PRAD-1 and HPV. Oncogene, 14, 811-818.
50. Dreyling, M.H., Bullinger, L., Ott, G., Stilgenbauer, S., Müller-Hermelink, H.K., Bentz, M., Hiddemann, W. and Döhner, H. (1997) Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma. Cancer Res., 57, 4608-4614.
51. Nielsen, N.H., Emdin, S.O., Cajander, J. and Landberg, G. (1997) Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein. Oncogene, 14, 295-304.
52. CDKN2B genes in certain B cell non-Hodgkin's lymphomas. Functional studies in a cell line (Grante 519). Leukemia, 11, 64-72.
53. Grønbæk, K., Nedergaard, T., Andersen, M.K., thor Straten, P., Guldberg, P., Møller, P., Zeuthen, J., Ebbe Hansen, N., Hou-Jensen, K. and Ralfkiaer, E. (1998) Concurrent disruption of cell cycle associated genes in mantle cell lymphoma: a genotypic and phenotypic study of cyclin D1, p16, p15, p53 and pRb. Leukemia, 12, 1266-1271.
54. INK4a in mouse lung tumors. Carcinogenesis, 18, 115-120.
55. Peeper, D.S., Upton, T.M., Ladha, M.H., Neuman, E., Zalvide, J., Bernards, R., DeCaprio, J.A. and Ewen, M.E. (1997) Ras signalling linked to the cell-cycle machinery by the retinoblasloma protein. Nature, 386, 177-181.
56. KIPI. Mol. Cell. Biol., 17, 3850-3857.
57. Sloan, S.R., Newcomb, E.W. and Pellicer, A. (1990) Neutron radiation can activate K-ras via a point mutation in codon 146 and induces a different spectrum of ras mutations than does gamma radiation. Mol. Cell. Biol., 10, 405-408.
58. Filmus, J., Robles, A.I., Shi, W., Wong, M.J., Colombo, L.L. and Conti, C.J. (1994) Induction of cyclin D1 overexpression by activated ras. Oncogene, 9, 3627-3633.
59. Lovec, H., Sewing, A., Lucibello, F.C., Müller, R. and Möröy, T. (1994) Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation. Oncogene, 9, 323-326.
60. Cordón-Cardo, C., Zhang, Z.-F., Dalbagni, G., Drobnjak, M., Charytonowicz, E., Hu, S.-X., Xu, H.-J., Reuter, V.E. and Benedict, W.F. (1997) Cooperative effects of p53 and pRB alterations in primary superficial bladder tumors. Cancer Res., 57, 1217-1221.
61. INK4 and retinoblastoma protein status in non-small cell lung cancer: potential synergistic effect with altered p53 protein on proliferative activity. Cancer Res., 56, 5557-5562.
62. Chin, L., Pomerantz, J., Polsky, D., Jacobson, M., Cohen, C., Cord'n-Cardo, C., Horner, J.W. and Depinho, R.A. (1997) Cooperative effects of INK4a and ras in melanoma susceptibility in vivo. Genes Dev., 11, 2822-2834.